Advanced precision diagnostics are reshaping cancer care by helping physicians identify the specific genetic mutations driving a patient’s disease and match treatments accordingly. In this Empowered Patient Podcast episode, Avalon CEO Dr. Bill Kerr, MD, explains how innovations such as liquid biopsy testing are accelerating cancer mutation analysis, reducing invasive procedures, and enabling faster, more personalized treatment decisions.
Dr. Kerr also discusses the growing impact of artificial intelligence in diagnostics, from improving the interpretation of complex test results to helping clinicians select the most effective therapies. Together, advanced diagnostics and AI are helping healthcare move toward earlier intervention, more precise care, and better patient outcomes.
Listen to the full podcast here:
